The Anticonvulsant FCE 26743 is a Selective and Short‐acting MAO‐B Inhibitor Devoid of Inducing Properties towards Cytochrome P450‐dependent Testosterone Hydroxylation in Mice and Rats

Journal of Pharmacy and Pharmacology

Volumn 46, Issue 10, 1994, Pages 814-819

  BENEDETTI, M STROLIN ^a   MARRARI, P ^a   COLOMBO, M ^a   CASTELLI, M G ^a   ARAND, M ^a,b   OESCH, F ^a,b   DOSTERT, P ^a  

^a Research and Development ^*  (Italy)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINAMIDE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTICONVULSIVE AGENT; BRAIN ENZYME; CARBAMAZEPINE; CYTOCHROME P450; DRUG METABOLITE; LIVER ENZYME; MONOAMINE OXIDASE INHIBITOR; PHENOBARBITAL; SAFINAMIDE; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG URINE LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; STEROID HYDROXYLATION; TISSUE HOMOGENATE; URINARY EXCRETION;

ALANINE; ANIMAL; ANTICONVULSANTS; BENZYLAMINES; BRAIN; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROXYLATION; IN VITRO; LIVER; MALE; MICE; MICE, INBRED STRAINS; MONOAMINE OXIDASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; TESTOSTERONE;

EID: 0028152976     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1994.tb03736.x     Document Type: Article

References (38)

1. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein‐dye binding
2. Differential changes in monoamine oxidase A and B activity in aging rat tissues
3. Conversion of orally administered 2‐n pentylaminoacetamide into glycinamide and glycine in the rat brain
4. Suppression of hydroxyl radical formation by MAO inhibitors: a novel possible neuroprotective mechanism in dopaminergic neurotoxicity
5. Monoamine oxidase and oxidative stress at dopaminergic synapses
6. Induction of microsomal cytochrome P‐450 enzymes: the first Bernard B. Brodie lecture at Pennsylvania State University
7. Different stereoselective inhibition of monoamine oxidase‐B by the R‐ and S‐enantiomers of MD 780236
8. Interactions of monoamine oxidase with substrates and inhibitors
9. New anticonvulsants with selective MAO‐B inhibitory activity
10. New tables for multiple comparisons with a control
11. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects
12. Levels of catechols in epileptogenic and nonepileptogenic regions of the human brain
13. Human cytochromes P‐450: problems and prospects
14. Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B
15. The novel neuropsychotropic agent milacemide is a specific enzyme‐activated inhibitor of brain monoamine oxidase
16. 3H]‐PK 11195 binding sites in human epileptic hippocampus
17. 5‐[4‐(Benzyloxy)phenyl]‐1,3,4‐oxadiazol‐2(3H)‐one derivatives and related analogues: new reversible, highly potent, and selective monoamine oxidase type B inhibitors
18. The role of lipid peroxidation in the possible involvement of membrane‐bound monoamine oxidases in gamma‐aminobutyric acid and glucosamine deamination in rat brain
19. Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy‐prone rats (GEPR‐9s)
20. Serotonin oxidation by type B MAO of rat brain
21. Is the oxidation of milacemide by monoamine oxidase a major factor in its anticonvulsant actions?
22. Improved sample preparation for the testosterone hydroxylation assay using disposable extraction columns
23. Effects of phenobarbital on lipid peroxidation in vitamin E‐deficients rats
24. Levels of biogenic amines, their metabolites, and tyrosine hydroxylase activity in the human epileptic temporal cortex
25. An anticonvulsant effect of monoamine oxidase inhibitors
26. On the alteration of catalytic properties of mitochondrial monoamine oxidases in experimental audiogenic epilepsia
27. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l‐deprenyl
28. Amino acid and catecholamine markers of metabolic abnormalities in human focal epilepsy
29. 3‐induced epileptogenic foci in the rat brain
30. Cardiazol‐induced seizures and the concentration of lipid peroxides in the brain of rats under the influence of valproic acid and vitamin E
31. Aliphatic amines as MAO substrates in the rat: the effect of selective inhibitors on the deamination of n‐pentylamine
32. The interactions of monoamine oxidase with some derivatives of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetra‐hydropyridine (MPTP)
33. The enzyme‐activated irreversible inhibition of type‐B monoamine oxidase by 3‐(4‐[(3‐chlorophenyl)methoxy]phenyl)‐5‐[(methylamino)methyl]‐2‐oxazolidinone methanesulphonate (compound MD780236) and the enzyme‐catalysed oxidation of this compound are competing reactions
34. 2+ injection
35. Effect of phenytoin and corticosteroids on seizures and lipid peroxidation in experimental posttraumatic epilepsy
36. The role of iron‐induced hippocampal peroxidation in acute epileptogenesis